Skip to content

Endocuff With or Without AI-assisted Colonoscopy

Endocuff With or Without Artificial Intelligence-assisted Colonoscopy in Detection of Colorectal Adenoma: a Randomized Colonoscopy Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05133544
Enrollment
656
Registered
2021-11-24
Start date
2022-05-01
Completion date
2024-02-29
Last updated
2023-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Adenoma, Colonic Cancer, Colonic Polyp

Keywords

Artificial intelligence, Colonoscopy, Endocuff, Detection, Computer-aided

Brief summary

Colonoscopy is considered the gold standard for diagnosis of colonic polyps. However, it was reported that colonoscopy could still miss colonic polyps. Many attempts have been made to improve the detection rate of colonoscopy. Artificial intelligence (AI) is a promising new technique to improve detection rate of colonic adenoma. However, it remains uncertain whether whether the combined use of Endocuff and AI assisted examination could help to further improve the adenoma detection rate. This is a prospective randomized trial comparing the use of endocuff with AI, AI alone or conventional colonoscopy examination on adenoma detection rate.

Detailed description

TThis is a prospective randomized tandem colonoscopy trial comparing three different modes of colonoscopy techniques. The first group will use Endocuff (Olympus, Hong Kong) and AI assisted colonoscopy. The second group will use AI assisted colonoscopy alone and the third group will use standard high-definition white light colonoscopy. Eligible patients will be randomly allocated in a 1:1:1 ratio to three groups. Patients will be stratified according to indications of colonoscopy (symptomatic vs screening/surveillance). All examination will be performed with high-definition endoscopes (EVIS-EXERA 290 video system, Olympus Optical, Tokyo, Japan) under white light by experienced endoscopists. All endoscopists should have received training on the interpretation of real-time AI detection system as well as the Endocuff before performing study colonoscopy. In all colonoscopy examination, colonoscope will be first advanced to the cecum as confirmed by identification of the appendiceal orifice and ileocecal valve or by intubation of the ileum. After cecal intubation is performed, the colonoscopy is first withdrawn according to the group assigned. For group 1, the first withdrawal would be done with Endocuff and AI assistance. For group 2, the first withdrawal would be done under AI assistance only. For group 3, the first withdrawal would be done under standard high definition colonoscopy only. All detected polyps will be removed during the withdrawal only. The size (measured with biopsy forceps), location and morphology of each polyp will be recorded by an independent observer. The withdrawal time (minus the polypectomy site) will be measured by a stopwatch and with a minimum of 6 minutes. The bowel preparation quality will be graded according to the Boston Bowel Preparation Scale

Interventions

DEVICEEndocuff with AI

Use of endocuff with computer assisted polyp detection

DEVICEAI alone

Use of computer assisted polyp detection

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All adult patients, aged 40 or above, undergoing outpatient colonoscopy in the Queen Mary Hospital, Tung Wah Hospital and Tuen Mun Hospital in Hong Kong will be recruited.

Exclusion criteria

* Patients will be excluded if they have history of inflammatory bowel disease, colorectal cancer, previous bowel resection, Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes, bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe. Moreover, after randomization, if the cecum could not be intubated for various reasons or Boston Bowel Preparation Scale (BBPS) score is \<2, these patients will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Adenoma detection rateOne month after colonoscopyThe proportion of patients with at least one adenomas

Secondary

MeasureTime frameDescription
Mean number of polyp per patientOne month after colonoscopyThe mean number of polyp per patient
Polyp detection rateOne month after colonoscopythe proportion of patients with at least one polyp
Sessile serrated adenomas detection rateOne month after colonoscopyThe proportion of patients with at least one sessile serrated adenomas
Advanced adenoma detection ratesOne month after colonoscopyThe proportion of patients with at least one advanced adenomas
Mean number of adenoma per patientOne month after colonoscopyThe mean number of adenoma per patient
Total number of polyp or adenoma per patient.One month after colonoscopyThe total number of polyp or adenoma per patient.
Sessile serrated polyps detection rateOne month after colonoscopyThe proportion of patients with at least one sessile serrated polyps

Countries

Hong Kong

Contacts

Primary ContactKa Luen, Thomas Lui, MBBS
klluitc@yahoo.com.hk22554048

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026